CTRI/2020/03/024057尚未招募未知
To compare the efficacy and safety of triple regimens Pantoperazole, Amoxicillin, Clarithromycin versus Pantoperazole, Metronidazole, Clarithromycin for Helicobacter Pylori Eradication in Dyspepsia patients; A Randomised controlled trial.
DR Rajendra Prasad Government Medical College Kangra at Tanda0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Dyspepsia patients (ulcer or non-ulcer) with H. pylori positivity on gastric biopsy.
排除标准
- •1) Patients not willing to give written informed consent.
- •2) Pregnant females.
- •3) Lactating females.
- •4) Active alcohol users.
- •5) Patients allergic or with known contraindications to any of study drugs.
- •6) Patients who have already taken either of the above mentioned H. pylori eradication
研究者
相似试验
已完成
4 期
Efficacy and safety of concomitant use of three immunosuppressant therapy for anti-MDA5 antibody-positive dermatomyositis with interstitial pneumoniadermatomyositis with interstitial pneumoniaJPRN-UMIN000014344Kyoto University Graduate School of Medicine25
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis.on-alcoholic steatohepatitisMedDRA version: 19.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-FRovo Nordisk A/S372
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis.on-alcoholic steatohepatitisMedDRA version: 22.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-NLovo Nordisk A/S288
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis.on-alcoholic steatohepatitisMedDRA version: 19.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-FIovo Nordisk A/S372
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis.on-alcoholic steatohepatitisMedDRA version: 20.1Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-DKovo Nordisk A/S288